- Report
- August 2022
- 40 Pages
Russia
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
- 40 Pages
Japan
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
- 40 Pages
Ireland
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
- 40 Pages
Germany
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
- 40 Pages
France
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
- 40 Pages
China
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
- 40 Pages
Brazil
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2022
- 80 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- November 2022
- 260 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Report
- August 2023
- 320 Pages
Global
From €3249EUR$3,570USD£2,785GBP

The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids.
The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more